[Can the correct dose be predicted by phase III?].
Dahan
R
R
Laboratoire Astra, Nanterre.
Jaillon
P
P
Lehner
J P
JP
D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016032:Randomized Controlled Trials as Topic
Peut-on prédire la bonne posologie de la phase III?